The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors
We demonstrated that low PgR expression is independently and significantly correlated with shorter PFS and OS. These findings support low PgR expression as a valuable prognostic biomarker in metastatic BC patients treated with first-line CDK4/6 inhibitors.
Authors
- İbrahim Vedat Bayoğlu (ORCID: https://orcid.org/0000-0002-0481-1084)
- Murat Günaltılı (ORCID: https://orcid.org/0000-0001-6116-3936)
- Mesut Yılmaz (ORCID: https://orcid.org/0000-0003-1466-3887)
- Özkan Alan (ORCID: https://orcid.org/0000-0002-6635-2012)
- Nargız Majidova (ORCID: https://orcid.org/0000-0002-2575-5819)
- İlkay Gültürk (ORCID: https://orcid.org/0000-0003-1998-3150)
- G. Sen (ORCID: https://orcid.org/0000-0003-4658-1552)
- Ali Kaan Güren (ORCID: https://orcid.org/0000-0002-3562-5006)
- Murad Guliyev (ORCID: https://orcid.org/0000-0002-2981-8098)
- Shamkhal Safarov (ORCID: https://orcid.org/0009-0000-8709-9768)
- Emre Özge (ORCID: https://orcid.org/0000-0002-8048-9090)
- Nebi Serkan Demirci (ORCID: https://orcid.org/0000-0001-5943-889X)
- Mehmet Cem Fidan (ORCID: https://orcid.org/0000-0002-7753-900X)
- Rumeysa Çolak (ORCID: https://orcid.org/0000-0002-3867-0793)
Institutions
- University of Health Science (KH)
- Istanbul University-Cerrahpaşa (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Marmara University (TR)
Publication Details
- Journal
- Cancers
- Published
- 2025-02-18
- DOI
- https://doi.org/10.3390/cancers17040693
- Citations
- 8
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 12.15